Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01473901 |
| Title | A Phase I Dose Escalation Study of BKM120 With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Novartis Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | ESP | CAN | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Highlands Oncology Group Highlands Oncology | Fayetteville | Arkansas | 72703 | United States | Details | |
| Dana Farber Cancer Institute SC (1) | Boston | Massachusetts | 02215 | United States | Details | |
| University of Texas/MD Anderson Cancer Center MD Anderson DeGrout | Houston | Texas | 77030-4009 | United States | Details | |
| Novartis Investigative Site | Melbourne | Victoria | 3000 | Australia | Details | |
| Novartis Investigative Site | Hamilton | Ontario | L8V 5C2 | Canada | Details | |
| Novartis Investigative Site | Toronto | Ontario | M5G 1Z6 | Canada | Details | |
| Novartis Investigative Site | Barcelona | Catalunya | 08035 | Spain | Details | |
| Novartis Investigative Site | Madrid | 28040 | Spain | Details |